Prosecution Insights
Last updated: October 02, 2026

Cellanome Inc.

Technology area: Biotechnology & Pharmaceuticals

5 pending office actions • 2 art units • 2 examiners • 0 of 5 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Analysis

Cellanome Inc. currently has 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 5 actions are being handled by 2 distinct examiners, which suggests a very focused interaction with the patent office's personnel. The portfolio is also distributed across 2 distinct art units, indicating that the company's applications touch upon different specialized areas within the Biotechnology & Pharmaceuticals sector.

The busiest examiner for the portfolio is Horlick, Kenneth R, who is responsible for 4 of the pending office actions. Since Horlick, Kenneth R manages 4 out of the 5 total actions, this examiner's specific feedback and requirements will be the primary factor in the company's current prosecution efforts. The 2 distinct art units involved mean that the 5 pending office actions are subject to the specific guidelines of two different examination groups, despite the small scale of the overall portfolio.

Practitioners managing these 5 pending office actions must prioritize the relationship with Horlick, Kenneth R, given their oversight of 4 cases. The presence of 2 distinct examiners and 2 distinct art units for 5 actions shows that the portfolio is concentrated in a few procedural silos. This distribution requires a tailored approach for each of the 5 pending office actions to address the specific technical nuances of the Biotechnology & Pharmaceuticals art units involved while accounting for the dominant role of the busiest examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
2
Medium (40%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
§112 only1 (20%)
Double-patenting + other1 (20%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HORLICK, KENNETH R 4 78.9% +15.3%
YAMASAKI, ROBERT J 1 67.6% +43.7%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19577221 METHODS FOR PERFORMING ASSAYS ON INDIVIDUAL LIVE CELLS HORLICK, KENNETH R —
19381382 DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES HORLICK, KENNETH R —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19577221 METHODS FOR PERFORMING ASSAYS ON INDIVIDUAL LIVE CELLS HORLICK, KENNETH R —
19577281 METHODS FOR FORMING ENCLOSURES AND PERFORMING ASSAYS ON A CELL WITHIN AN ENCLOSURE HORLICK, KENNETH R —
19538691 METHODS FOR INCUBATING AND ANALYZING A CELL IN A COMPARTMENT OF A FLUIDIC DEVICE HORLICK, KENNETH R —
19459949 METHODS FOR IMMOBILIZING AND SORTING A CELL USING LIGHT YAMASAKI, ROBERT J —
19381382 DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES HORLICK, KENNETH R —

Top Art Units

Art UnitApps
1681 4
1657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19577221 METHODS FOR PERFORMING ASSAYS ON INDIVIDUAL LIVE CELLS HORLICK, KENNETH R 1681 §102§103 Final Rejection — Pending Mar 24, 2026
19577281 METHODS FOR FORMING ENCLOSURES AND PERFORMING ASSAYS ON A CELL WITHIN AN ENCLOSURE HORLICK, KENNETH R 1681 §112 Non-Final OA — Pending Mar 24, 2026
19538691 METHODS FOR INCUBATING AND ANALYZING A CELL IN A COMPARTMENT OF A FLUIDIC DEVICE HORLICK, KENNETH R 1681 §103 Non-Final OA — Pending Feb 12, 2026
19459949 METHODS FOR IMMOBILIZING AND SORTING A CELL USING LIGHT YAMASAKI, ROBERT J 1657 §102§103DP Non-Final OA — Pending Jan 26, 2026
19381382 DEVICES AND METHODS FOR ANALYZING BIOLOGICAL SAMPLES HORLICK, KENNETH R 1681 §102§103 Non-Final OA — Pending Nov 06, 2025

Managing Cellanome Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month